Clinical Trials

Structural Nanomedicine in Cancer – Review
Research & Development Structural Nanomedicine in Cancer – Review

Cancer remains one of the most formidable challenges in modern medicine, with treatments like chemotherapy often causing as much harm as help due to their indiscriminate attack on both cancerous and healthy cells. Imagine a scenario where a drug could be delivered with pinpoint accuracy, targeting

How Are NK Cell Therapies Revolutionizing Cancer Treatment?
Research & Development How Are NK Cell Therapies Revolutionizing Cancer Treatment?

In the ever-evolving battle against cancer, a new frontier has emerged that promises to transform the landscape of treatment, particularly for stubborn solid tumors such as those found in breast, colorectal, pancreatic, and lung cancers. Natural Killer (NK) cell therapies, leveraging a unique

Tempus AI Secures FDA Clearance for xR IVD Oncology Device
Research & Development Tempus AI Secures FDA Clearance for xR IVD Oncology Device

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, paired with a deep understanding of technology and innovation, has positioned him as a thought leader in the healthcare industry. Today, we’ll explore groundbreaking

Mount Sinai's $4.5M Grant to Decode Bipolar Brain Mechanisms
Tech & Innovation Mount Sinai's $4.5M Grant to Decode Bipolar Brain Mechanisms

What drives the extreme emotional rollercoaster of bipolar disorder, where manic highs can spiral into crushing depressive lows in a matter of days, leaving millions worldwide searching for answers? This question haunts not only those affected but also the scientists striving to unravel the brain's

Can Welireg Redefine Kidney Cancer Treatment Success?
Research & Development Can Welireg Redefine Kidney Cancer Treatment Success?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a keen understanding of technological innovation in the industry. Today, we’re diving into the exciting developments surrounding Merck's kidney cancer drug

Recombinant Human Collagen III Transforms Tissue Engineering
Biotech & Bioprocessing Recombinant Human Collagen III Transforms Tissue Engineering

In the rapidly evolving landscape of regenerative medicine, a groundbreaking biomaterial known as recombinant human type III collagen (rhCol III) is capturing the attention of scientists and medical professionals alike, marking a significant advancement. This innovative substance, crafted through

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later